These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17371980)

  • 1. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition.
    Sevigny CP; Li L; Awad AS; Huang L; McDuffie M; Linden J; Lobo PI; Okusa MD
    J Immunol; 2007 Apr; 178(7):4240-9. PubMed ID: 17371980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
    Lappas CM; Rieger JM; Linden J
    J Immunol; 2005 Jan; 174(2):1073-80. PubMed ID: 15634932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.
    Sharma AK; Laubach VE; Ramos SI; Zhao Y; Stukenborg G; Linden J; Kron IL; Yang Z
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):474-82. PubMed ID: 19909990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence.
    Alam MS; Kurtz CC; Wilson JM; Burnette BR; Wiznerowicz EB; Ross WG; Rieger JM; Figler RA; Linden J; Crowe SE; Ernst PB
    Mucosal Immunol; 2009 May; 2(3):232-42. PubMed ID: 19262506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
    Day YJ; Marshall MA; Huang L; McDuffie MJ; Okusa MD; Linden J
    Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G285-93. PubMed ID: 14715520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury.
    Day YJ; Li Y; Rieger JM; Ramos SI; Okusa MD; Linden J
    J Immunol; 2005 Apr; 174(8):5040-6. PubMed ID: 15814735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.
    Coenen JJ; Koenen HJ; van Rijssen E; Boon L; Joosten I; Hilbrands LB
    J Immunol; 2006 May; 176(9):5240-6. PubMed ID: 16621989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine 2A receptors preserves structure and function of podocytes.
    Awad AS; Rouse M; Liu L; Vergis AL; Rosin DL; Linden J; Sedor JR; Okusa MD
    J Am Soc Nephrol; 2008 Jan; 19(1):59-68. PubMed ID: 18045850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.
    Chhabra P; Wang K; Zeng Q; Jecmenica M; Langman L; Linden J; Ketchum RJ; Brayman KL
    Cell Transplant; 2010; 19(5):597-612. PubMed ID: 20350347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation.
    Sharma AK; Linden J; Kron IL; Laubach VE
    Respir Res; 2009 Jun; 10(1):58. PubMed ID: 19558673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain.
    Loram LC; Harrison JA; Sloane EM; Hutchinson MR; Sholar P; Taylor FR; Berkelhammer D; Coats BD; Poole S; Milligan ED; Maier SF; Rieger J; Watkins LR
    J Neurosci; 2009 Nov; 29(44):14015-25. PubMed ID: 19890011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation.
    Ohtsuka T; Changelian PS; Bouïs D; Noon K; Harada H; Lama VN; Pinsky DJ
    J Immunol; 2010 Jul; 185(2):1321-9. PubMed ID: 20548026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Domenig C; Habicht A; Najafian N; Yagita H; Azuma M; Turka LA; Sayegh MH
    J Immunol; 2005 Mar; 174(6):3408-15. PubMed ID: 15749874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mosaic of immunosuppressive drugs.
    Masri MA
    Mol Immunol; 2003 Jul; 39(17-18):1073-7. PubMed ID: 12835079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.